Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group - Levin, M; Quint, P A; Goldstein, B (Lancet, 2000)
(9234):